Gujrathi Sheila - Insider Non-Derivative Transactions at Janux Therapeutics, Inc. (JANX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 26, 2024, Gujrathi Sheila's relationship to Janux Therapeutics, Inc. (JANX) is Director, and currently has 110,528 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other JANX insiders.

Data Source: SEC.
Gujrathi Sheila - Insider Non-Derivative Transactions of JANX Common Stock
Gujrathi Sheila - Insider Non-Derivative Transactions at JANX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 27, 2024 Acquisition -- (Common Stock) 2500 0 110528
Mar 1, 2024 J -- (Common Stock) 2986 0 108028